MAHBOOB VASEEM (Chief Financial Officer) sold 16.2% of their position (18.19K shares) of KESTRA MEDICAL TECHNOLOGIES, LTD. on the open market
Open‑market sale worth $418.2K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 8/3/2026ACC: 0001193125-26-331062
Officer· Chief Financial Officer
Since Mar 2025
-18.19K
Net shares
Net seller
$418.2K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
18.19K disposed
Non-Derivative Transactions3
Common Shares
Direct
Shares
−3.98K
Price / share
$22.75
Trade value
$90.56K
% of position
3.6%
7/30/2026
112.08K→108.10K
Common Shares
Direct
Shares
−8.82K
Price / share
$22.61
Trade value
$199.34K
% of position
8.2%
7/31/2026
108.10K→99.28K
Common Shares
Direct
Shares
−5.39K
Price / share
$23.80
Trade value
$128.31K
% of position
5.4%
8/3/2026
99.28K→93.89K
Total
Net shares
−18.19K
Net value
-$418.22K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 7/30/2026 | S · Sale | −3.98K | $22.75 | $90.56K | 3.6% | 112.08K | 108.10K |
| Common Shares Direct | 7/31/2026 | S · Sale | −8.82K | $22.61 | $199.34K | 8.2% | 108.10K | 99.28K |
| Common Shares Direct | 8/3/2026 | S · Sale | −5.39K | $23.80 | $128.31K | 5.4% | 99.28K | 93.89K |
| Total | −18.19K | -$418.22K | ||||||
Derivative Transactions0
No derivative transactions reported